Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
FlunitrazepamCat. No. 4047 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Chemical Name: 5-(2-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one |
Biological Activity
Ligand at the GABAA receptor benzodiazepine modulatory site. Exhibits hypnotic effects; also displays anxiolytic and sedative properties.Certificate of Analysis / Safety Data Sheet
References
Merck Index 14 4146.
Johnston et al (1998) Flunitrazepam rapidly reduces GABAA receptor subunit protein expression via a protein kinase C-dependent mechanism. Br.J.Pharmacol. 124 1338. PMID: 9723942.
Malanciuc et al (2009) Analytical characterization of flunitrazepam. Farmacia 57 167.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: Flunitrazepam, supplier, hypnotic, benzodiazepine, gabaa, receptors, modulatory, binding, sites, agonists
Quick Order
Find multiple products by catalog number
Pain Research Product Guide
Highlights over 280 products for Pain research. Request copy or view PDF today.
Therapeutic Strategies in Schizophrenia
Written by J. Lieberman
'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.
Tocris Events
Win a Kindle
June 21, 2013
London, UK